Diphenhydramine Hydrochloride
FDA Label NDC 76413-306

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Central Texas Community Health Centers for the product Diphenhydramine Hydrochloride (NDC 76413-306). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each banded capsule), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant of breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Principal Display Panel - 25 Mg Capsule Blister Pack Carton Label

CommUnityCare Federally Qualified Health Centers

DIPHENHYDRAMINE
25mg/24 Caps

Date:

Name:
Dr.

USE AS DIRECTED.

123456

1/1/01

DIPHENHYDRAMINE 25mg/24 CAPS NDC 76413-306-24

Batch: 123456
Lot: 123456
Exp: 1/1/01
MAJOR

Federal law prohibits the transfer of this drug to any other person than the patient for whom prescribed.

Principal Display Panel (25 mg Capsule Blister Pack Carton Label)

Principal Display Panel (25 mg Capsule Blister Pack Carton Label)

* Please review the disclaimer below.